159 related articles for article (PubMed ID: 31401665)
21. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
22. Adipophilin expression in skin lesions with clear cell histology.
Li FZ; Ye Q; Ran LW; Fang S
J Clin Pathol; 2022 Sep; 75(9):627-631. PubMed ID: 33952590
[TBL] [Abstract][Full Text] [Related]
23. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
24. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
25. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
26. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
Chen WS; Chen PL; Li J; Lind AC; Lu D
J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
29. Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid.
Tanahashi J; Kashima K; Daa T; Yada N; Fujiwara S; Yokoyama S
J Cutan Pathol; 2009 Sep; 36(9):983-6. PubMed ID: 19017040
[TBL] [Abstract][Full Text] [Related]
30. Basal cell carcinoma with sebaceous differentiation.
Misago N; Suse T; Uemura T; Narisawa Y
Am J Dermatopathol; 2004 Aug; 26(4):298-303. PubMed ID: 15249860
[TBL] [Abstract][Full Text] [Related]
31. [Sebaceous carcinoma in situ in extraocular skin : Case report and discussion of the new entity].
Hrudka J; Bezvodová A; Arenbergerová M; Sticová E; Bandke D
Hautarzt; 2020 Jan; 71(1):57-62. PubMed ID: 31420711
[TBL] [Abstract][Full Text] [Related]
32. Low-grade sebaceous carcinoma presenting on the leg.
Imakado S; Hamada K; Miura K
Am J Dermatopathol; 2008 Dec; 30(6):608-11. PubMed ID: 19033940
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratins in normal thymus and thymic epithelial tumors.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
[TBL] [Abstract][Full Text] [Related]
34. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.
Gu X; Huang Z; Chen J; Luo Y; Ge S; Jia R; Song X; Chai P; Xu S; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):16. PubMed ID: 38095907
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
36. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical staining for adipophilin, perilipin and TIP47.
Muthusamy K; Halbert G; Roberts F
J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
[TBL] [Abstract][Full Text] [Related]
38. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma.
Hayashi A; Fumon T; Miki Y; Sato H; Yoshino T; Takahashi K
J Clin Exp Hematop; 2013; 53(1):9-19. PubMed ID: 23801129
[TBL] [Abstract][Full Text] [Related]
39. Cytomorphology of sebaceous carcinoma with analysis of p40 antibody expression.
Jain D; Mathur SR; Sharma MC; Iyer VK
Diagn Cytopathol; 2015 Jun; 43(6):456-61. PubMed ID: 25611456
[TBL] [Abstract][Full Text] [Related]
40. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
